Skip to content
Nabriva Therapeutics PLC icon

Nabriva Therapeutics PLC

NBRVFStocksPharmaceuticals MajorIrelandOTC Markets Stock ExchangeUSD

Price

$1.33

Today

+0.0%

YTD

+0.0%

About

Nabriva Therapeutics is a biopharmaceutical company with headquarters in Dublin, Ireland. Operating locally, the company develops and commercialises novel anti-infective agents that are used to treat serious infections. Founded in 2006, the company is listed on the NASDAQ GS stock market using the ticker of NBRV. Increase your eToro portfolio's diversity by adding NBRV stock to your holdings.

Price chart
Closing price history for NBRVF (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)0.00
P/S (TTM)0.00
P/B (TTM)0.00
Market cap$300.00
Cap tierMicro-cap
Industry avg P/E-43.30

Profitability

Gross margin-15.97%
EBIT margin-164.54%
Net margin-537.76%
ROE-602.21%
ROA-168.18%

Earnings & Revenue

Revenue (TTM)$29.56M
Revenue growth (1Y)-16.3%
EPS (TTM)-$17.78
Free cash flow$-12.72M
Total debt$540,000.00

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)125.98
Employees39
Next earnings3 Aug '23
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Nabriva Therapeutics PLC (NBRVF) | Dirk Kuyken